{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:09:11Z","timestamp":1780621751470,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpba.2025.116803","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T22:51:01Z","timestamp":1741474261000},"page":"116803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A sensitive method for the profiling of phenyl- and indole-containing metabolites in blood serum and cerebrospinal fluid samples of patients with severe brain damage using ultra-high-pressure liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"260","author":[{"given":"Pavel D.","family":"Sobolev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Burnakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Revelsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav E.","family":"Zakharchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Beloborodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-0485","authenticated-orcid":false,"given":"Alisa K.","family":"Pautova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116803_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra0804573","article-title":"Nosocomial bacterial meningitis","volume":"362","author":"van de Beek","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2025.116803_bib2","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 infectious diseases society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2025.116803_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneuroim.2012.01.009","article-title":"The role of metabolomics in neurological disease","volume":"248","author":"Hassan-Smith","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jpba.2025.116803_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115685","article-title":"Application of metabolomics in diagnostics and differentiation of meningitis: a narrative review with a critical approach to the literature","volume":"168","author":"Kozio\u0142","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.jpba.2025.116803_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/dmcn.14774","article-title":"Cerebrospinal fluid metabolites in tryptophan-kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation","volume":"63","author":"Yan","year":"2021","journal-title":"Dev. Med Child Neurol."},{"key":"10.1016\/j.jpba.2025.116803_bib6","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1016\/j.csbj.2021.05.024","article-title":"Machine learning applied to serum and cerebrospinal fluid metabolomes revealed altered arginine metabolism in neonatal sepsis with meningoencephalitis","volume":"19","author":"Zhang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jpba.2025.116803_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/jpm12030399","article-title":"4-hydroxyphenyllactic acid in cerebrospinal fluid as a possible marker of post-neurosurgical meningitis: retrospective study","volume":"12","author":"Pautova","year":"2022","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.jpba.2025.116803_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2025.116803_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bmc.4969","article-title":"Metabolic profiling of aromatic compounds in cerebrospinal fluid of neurosurgical patients using microextraction by packed sorbent and liquid\u2013liquid extraction with gas chromatography\u2013mass spectrometry analysis","volume":"35","author":"Pautova","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2025.116803_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13111128","article-title":"Analysis of 4-hydroxyphenyllactic acid and other diagnostically important metabolites of \u03b1-amino acids in human blood serum using a validated and sensitive ultra-high-pressure liquid chromatography-tandem mass spectrometry method","volume":"13","author":"Sobolev","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2025.116803_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.4155\/bio-2018-0140","article-title":"Quantification of phenolic acid metabolites in humans by LC\u2013MS: a structural and targeted metabolomics approach","volume":"10","author":"Obrenovich","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.116803_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0021-9673(99)00973-5","article-title":"Screening for defects in tryptophan metabolism","volume":"870","author":"Marklov\u00e1","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.116803_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4985","article-title":"Rapid simultaneous determination of gut microbial phenylalanine, tyrosine, and tryptophan metabolites in rat serum, urine, and faeces using LC\u2013MS\/MS and its application to a type 2 diabetes mellitus study","volume":"35","author":"Zou","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2025.116803_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jchromb.2012.07.040","article-title":"Validation of determination of plasma metabolites derived from thyme bioactive compounds by improved liquid chromatography coupled to tandem mass spectrometry","volume":"905","author":"Rubi\u00f3","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.116803_bib15","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/jssc.201900258","article-title":"Trace enrichment of phenylcarboxylic acids from a model biological fluid and serum of human blood","volume":"42","author":"Popov","year":"2019","journal-title":"J. Sep Sci."},{"key":"10.1016\/j.jpba.2025.116803_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122511","article-title":"A targeted ultra performance liquid chromatography \u2013 Tandem mass spectrometric assay for tyrosine and metabolites in urine and plasma: Application to the effects of antibiotics on mice","volume":"1164","author":"Letertre","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.116803_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/00032719.2013.871549","article-title":"Determination of tyrosine and its metabolites in human serum with application to cancer diagnosis","volume":"47","author":"Feng","year":"2014","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jpba.2025.116803_bib18","unstructured":"FDA, Cder, Bioanalytical Method Validation Guidance for Industry Biopharmaceutics Bioanalytical Method Validation Guidance for Industry Biopharmaceutics Contains Nonbinding Recommendations, (2018)."},{"key":"10.1016\/j.jpba.2025.116803_bib19","unstructured":"EMEA\/CHMP, ICH guideline M10 on bioanalytical method validation and study sample analysis - Committee for Medicinal Products for Human Use (CHMP), EuropeanMedicines Agency (2022)."},{"key":"10.1016\/j.jpba.2025.116803_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4155\/bio-2018-0105","article-title":"Proposed selection strategy of surrogate matrix to quantify endogenous substances by Japan Bioanalysis Forum DG2015-15","volume":"10","author":"Wakamatsu","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.116803_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpba.2016.06.017","article-title":"Quantitative analysis of endogenous compounds","volume":"128","author":"Thakare","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116803_bib22","article-title":"Sepsis-Associated Metabolites and Their Biotransformation by Intestinal Microbiota","volume":"19","author":"Chernevskaya","year":"2023","journal-title":"Obshchaya Reanimatol."},{"key":"10.1016\/j.jpba.2025.116803_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1381612826666201022121653","article-title":"Indolic structure metabolites as potential biomarkers of non-infectious diseases","volume":"27","author":"Beloborodova","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2025.116803_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/jpm13060971","article-title":"Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome","volume":"13","author":"Sorokina","year":"2023","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.jpba.2025.116803_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo11020122","article-title":"Host-microbiome interactions mediated by phenolic metabolites in chronically critically ill patients","volume":"11","author":"Chernevskaya","year":"2021","journal-title":"Metabolites"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852500144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:22:42Z","timestamp":1744237362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852500144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":25,"alternative-id":["S073170852500144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116803","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive method for the profiling of phenyl- and indole-containing metabolites in blood serum and cerebrospinal fluid samples of patients with severe brain damage using ultra-high-pressure liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116803"}}